Pfizer Inc. (NYSE:PFE) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider of Goldman ...

China's biotechnology stocks have experienced a significant rally, outperforming AI, with a 60% surge since January due to ...

The surge in China-listed biotech firms is further evidence that the mainland is becoming a center for global innovation ...

According to TipRanks.com, Huynh is a 5-star analyst with an average return of 13.3% and a 68.9% success rate. Huynh covers the Healthcare sector, focusing on stocks such as Acumen Pharmaceuticals, ...

German biotechnology company BioNTech is making a bold move to expand its cancer research efforts with a $1.25 billion all-stock acquisition of CureVac . The deal is expected to e ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...

BioNTech's $1.25 billion acquisition of CureVac creates a "German biotech champion" focused on mRNA-based cancer treatments, with CureVac shares surging 38% on the announcement.

BioNTech agreed to buy CureVac for $1.25 billion, expanding its mRNA cancer research and boosting its oncology pipeline.

Dividend stocks can set you up for life. But, making the right choice will determine whether you enjoy a steady income or ...